Catalog No.
YHM00102
Expression system
E. coli
Species
Homo sapiens (Human)
Protein length
Gly25-Leu300
Predicted molecular weight
34.12 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
P04439
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
HLAA, Human leukocyte antigen A, HLA class I histocompatibility antigen, A alpha chain, HLA-A
Acute Lymphoblastic Leukemia and Associated HLA-A, B, DRB1, and DQB1 Molecules: A Moroccan Pediatric Case-Control Study., PMID:40508101
Characterization of HLA-A/HLA-B/HLA-C/HLA-DRB1 Haplotypes in Romanian Stem Cell Donors Through High-Resolution Next-Generation Sequencing., PMID:40508057
Solution mapping of MHC-I:TCR interactions using a minimalistic protein system., PMID:40489613
Characterisation of the Novel HLA-A*03:01:133 Allele by Next-Generation Sequencing in Brazil., PMID:40484733
Predominant T-cell epitopes of SARS-CoV-2 restricted by multiple prevalent HLA-B and HLA-C allotypes in Northeast Asia., PMID:40469303
Characterisation of the Novel HLA-A*68:326 and -C*02:254N Alleles by Two Different Sequencing-Based Typing Techniques., PMID:40462530
Asymptomatic SARS-CoV-2 Infection: Association Involving the HLA-B*15 Allele Group in Brazilian Individuals., PMID:40451247
Identification of shared neoantigens derived from frameshift mutations in the APC gene., PMID:40443655
Bispecific antibody targeting shared indel-derived neoantigen of APC., PMID:40443649
TEIPP-vaccination in checkpoint-resistant non-small cell lung cancer: a first-in-human phase I/II dose-escalation study., PMID:40436854
Characterisation of the Novel HLA-A*24:642 Allele Using New Next-Generation Sequencing Methods., PMID:40434046
Serum starvation-induced cholesterol reduction increases melanoma cell susceptibility to cytotoxic T lymphocyte killing., PMID:40419522
ESMpHLA: Evolutionary Scale Model-Based Deep Learning Prediction of HLA Class I Binding Peptides., PMID:40405507
Investigating the role of necroptosis in the immunological microenvironment of periodontitis., PMID:40402323
Targeting intracellular LMP2 with costimulatory signal-armed antibody-like TCR T cells., PMID:40401520
Shared neoantigens' atlas for off-the-shelf cancer vaccine development., PMID:40390041
Repeated HLA-DRB1 and HLA-DQB1 Mismatches Without Preformed DSA Affect Graft Survival, Rejection and DSA Development: A Multicenter Analysis., PMID:40387242
HLA Polymorphisms and COVID-19 Susceptibility and Severity: Insights From an Iranian Patients Cohort., PMID:40366340
Regional distribution of HLA frequencies in the USA: implications for TCR-based therapies., PMID:40360437
[Identification of a case with novel HLA-DRB1*12:106 allele]., PMID:40350392
T cell memory response to MPXV infection exhibits greater effector function and migratory potential compared to MVA-BN vaccination., PMID:40348752
Differential reactivity of SARS-CoV-2 S-protein T-cell epitopes in vaccinated versus naturally infected individuals., PMID:40342296
Immunogenicity of Trypanosoma cruzi Multi-Epitope Recombinant Protein as an Antigen Candidate for Chagas Disease Vaccine in Humans., PMID:40333154
The Novel HLA-A*26:254 Allele Identified From a Mestizo From Ecuador., PMID:40331675
Characterisation of the Novel HLA-A*68:322 Allele by Sequencing-Based Typing., PMID:40331658
The Novel HLA-A*68 Allele, HLA-A*68:02:27, Identified by Next Generation Sequencing., PMID:40331536
Identification of the Novel HLA-A*31:239 Allele by Next-Generation Sequencing., PMID:40326638
Discovery of the HLA-A*29:01:15 Allele, a Variant of HLA-A*29 in a Chinese Individual., PMID:40326549
HLA-A*02:11:01:08 and HLA-A*11:01:01:91 Identified in Two Unrelated Prospective Bone Marrow Donors in India., PMID:40323281
Characterisation of the Novel HLA-A*32:01:64 Allele by Sequencing-Based Typing., PMID:40313232
Tebentafusp elicits on-target cutaneous immune responses driven by cytotoxic T-cells in uveal melanoma patients., PMID:40311102
Fully Characterised Genomic Sequence of the HLA-A*02:446 Allele Identified by Long-Range PCR, Cloning and Sequencing., PMID:40308073
Identification of the Novel HLA-A*24:649 Allele by Next-Generation Sequencing in a Chinese Individual., PMID:40308065
Characterisation of the Novel HLA-A*68:02:26 Allele by Sequencing-Based Typing., PMID:40308060
Characterisation of the Novel HLA-A*68:331 Allele by Sequencing-Based Typing., PMID:40304353
HLA alleles and dengue susceptibility across populations in the era of climate change: a comprehensive review., PMID:40303409
Conversion Surgery Performed Following Durvalumab Combined With Gemcitabine and Cisplatin in Cholangiocarcinoma: A Case Report., PMID:40294984
Identification of new HLA-A*0201-restricted cytotoxic T lymphocyte epitopes from LDHC in lung adenocarcinoma., PMID:40270965
Cost-Effective and Highly Scalable Typing of HLA Classes I and II Genes of up to 96 Individuals Using Nanopore Sequencing., PMID:40270210
Evaluating the Antigen and Eplet Accuracy of DQA1 Imputations With the HaploSFHI Two-Field HLA Typing Inference Tool., PMID:40269614
Characterisation of the Novel HLA-A*01:470 Allele by Sequencing-Based Typing., PMID:40256977
Detection of the HLA-A*02:924 Allele, a Variant of A*02:07:01:01, in a Taiwanese Individual., PMID:40251937
Characterisation of the Novel HLA-A*01:01:01:121 Allele by Next Generation Sequencing., PMID:40251901
The Novel Allele HLA-A*26:01:80 Was Identified in a Chinese Individual., PMID:40243141
HLA Class I and II allelic diversity among Ecuadorian transplant candidates: A comprehensive retrospective analysis., PMID:40239304
LOXHD1 is an oncofusion-regulated antigen of ewing sarcoma., PMID:40234527
Beyond Checkpoint Inhibition: Keeping Therapeutic Options Open., PMID:40233298
Nanoneedle-Based Electroporation for Efficient Manufacturing of Human Primary Chimeric Antigen Receptor Regulatory T-Cells., PMID:40231643
Design and development of highly conserved, HLA-promiscuous T cell multiepitope vaccines against human visceral leishmaniasis., PMID:40230841
Selective Deletion of HLA-B, and -C Class I Genes Promotes Immunocompatibility of Humanized Skin Graft Model., PMID:40230599
For research use only. Not for human or drug use.
